Top

Published in:

01-12-2011 | Erratum

Erratum to: The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK

Authors: Á Benedict, L Verdian, G Maclaine

Published in: PharmacoEconomics | Issue 12/2011

Excerpt

Benedict Á, Verdian L, Maclaine G. The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK. PharmacoEconomics 2010; 28 (3): 185–99 …

Title: Erratum to: The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK
Authors: Á Benedict
L Verdian
G Maclaine
Publication date: 01-12-2011
Publisher: Springer International Publishing
Published in: PharmacoEconomics / Issue 12/2011
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI: https://doi.org/10.2165/11598620-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Erratum to: The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2011

Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection

Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy

Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective

Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease

Acknowledgment

QALYs and Carers